Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Clinical trial NCT03085810 · TERMINATED
Trial details
- NCT number
- NCT03085810
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-24
- Primary completion
- 2023-04-27
- Enrollment
- 1225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.